Pfizer Inc (PFE)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 88,203,000 | 92,286,000 | 87,700,000 | 92,282,000 | 89,014,000 | 96,934,000 | 99,019,000 | 100,971,000 | 95,661,000 | 92,631,000 | 87,209,000 | 82,424,000 | 77,201,000 | 75,691,000 | 70,042,000 | 68,620,000 | 63,238,000 | 65,259,000 | 64,336,000 | 65,026,000 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $88,203,000K)
= 0.00
The debt-to-capital ratio for Pfizer Inc remained consistently at 0.00 from March 2020 to December 2024. This implies that Pfizer's total debt in relation to its total capital (both equity and debt) was negligible or effectively non-existent during this period. A debt-to-capital ratio of 0.00 indicates that the company's capital structure was predominantly equity-funded rather than debt-financed. This could suggest a strong financial position, low financial risk, and potentially lower interest expenses for Pfizer Inc, as it did not heavily rely on debt to finance its operations and growth.
Peer comparison
Dec 31, 2024